Page last updated: 2024-08-22

betamethasone-17,21-dipropionate and Mouth Neoplasms

betamethasone-17,21-dipropionate has been researched along with Mouth Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García-Legaz Martínez, M; Magdaleno-Tapial, J; Martínez-Doménech, Á; Pérez-Ferriols, A; Pérez-Pastor, G; Valenzuela-Oñate, C1

Other Studies

1 other study(ies) available for betamethasone-17,21-dipropionate and Mouth Neoplasms

ArticleYear
Digital ulcerative lichenoid dermatitis in a patient receiving anti-PD-1 therapy.
    Dermatology online journal, 2019, Sep-15, Volume: 25, Issue:9

    Topics: Administration, Cutaneous; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Betamethasone; Carcinoma, Squamous Cell; Drug Combinations; Gentamicins; Humans; Lichenoid Eruptions; Male; Mouth Neoplasms; Programmed Cell Death 1 Receptor; Skin; Skin Ulcer

2019